The AXL receptor tyrosine kinase (RTK) is linked with cell proliferation, migration, and neoplasm and also promotes epithelial‐mesenchymal transition (EMT), a significant factor in drug‐resistance metastasis (Yan et al. 2021). This evidence concerns the gene NTRK1 and neoplasm.